Medicare Enrolled

Dr. Enrique Griego, M.D.

Family Medicine · McAllen, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1900 S JACKSON RD STE 9, McAllen, TX 78503
9566876667
In practice since 2006 (19 years)
NPI: 1164432506 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Griego from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Griego? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Griego

Dr. Enrique Griego is a family medicine in McAllen, TX, with 19 years in practice. Based on federal Medicare data, Dr. Griego performed 6,213 Medicare services across 3,280 unique beneficiaries.

Between the years covered by Open Payments, Dr. Griego received a total of $215,705 from 59 pharmaceutical and/or device companies across 1286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Griego is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 2% volume in TX$ $215,705 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,213
Medicare services
Top 2% in TX for family medicine
3,280
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~327 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)815$55$120
Insertion of needle into vein (3 years or older)463$11$21
Complete blood count (CBC) with differential428$8$25
Basic metabolic blood panel421$8$25
Lactate dehydrogenase (enzyme) level421$6$20
Liver function blood test panel416$8$25
Lipid panel (cholesterol and triglycerides)399$13$50
Glutamyltransferase (liver enzyme) level396$7$30
Hemoglobin A1c test (diabetes monitoring)272$10$40
Vitamin D level test218$29$75
Automated urinalysis193$2$10
Creatinine test (kidney function)189$5$20
Blood glucose (sugar) level184$4$15
Thyroid stimulating hormone (TSH) test163$16$50
Office visit, established patient (30-39 min)139$85$170
Drug injection, under skin or into muscle122$9$30
Ceftriaxone antibiotic injection118$0$15
Office visit, established patient (10-19 min)88$35$80
Electrocardiogram (EKG), 12-lead78$9$50
Dexamethasone injection (steroid)78$0$20
Injection, lidocaine hcl for intravenous infusion, 10 mg69$0$10
Annual wellness visit, follow-up64$124$250
Annual depression screening63$18$100
Ultrasound study of arm and leg arteries49$56$165
Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage43$22$25
Flu vaccine administration42$29$30
Testing of autonomic nervous system function and heart rate response to deep breathing41$63$105
Testing of autonomic (sympathetic) nervous system function38$72$250
Prostate cancer screening; prostate specific antigen test (psa)37$19$60
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg32$1$10
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional22$13$50
Transitional care management services for problem of high complexity20$211$445
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous18$18$50
Complete ultrasound scan of abdomen17$79$200
New patient office visit (30-44 min)17$55$170
Bone density scan (DEXA)15$36$100
Retinal photography (fundus photo)14$18$150
Complete ultrasound scan of pelvis11$52$165
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
6.9% medium
92.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$215,705
Total received (2018-2024)
Avg $30,815/year across 7 years
Top 0% in TX for family medicine
59
Companies
1,286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$205,282 (95.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,423 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,661
2023
$14,290
2022
$23,321
2021
$12,143
2020
$22,090
2019
$74,042
2018
$54,159

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$77,462
Amarin Pharma Inc.
$49,343
Lilly USA, LLC
$32,888
Boehringer Ingelheim Pharmaceuticals, Inc.
$28,564
Janssen Pharmaceuticals, Inc
$17,883
AstraZeneca Pharmaceuticals LP
$2,379
Amgen Inc.
$1,009
Novartis Pharmaceuticals Corporation
$635
GlaxoSmithKline, LLC.
$591
Merck Sharp & Dohme Corporation
$574
Astellas Pharma US Inc
$550
ABBVIE INC.
$468
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$361
PFIZER INC.
$303
SANOFI-AVENTIS U.S. LLC
$257
Takeda Pharmaceuticals U.S.A., Inc.
$201
Corcept Therapeutics
$186
Esperion Therapeutics, Inc.
$177
Eisai Inc.
$159
Synergy Pharmaceuticals Inc
$139
Bayer HealthCare Pharmaceuticals Inc.
$116
Dexcom, Inc.
$113
Echosens North America, Inc.
$100
UROVANT SCIENCES INC
$99
Kowa Pharmaceuticals America, Inc.
$76
Abbott Laboratories
$73
Regeneron Healthcare Solutions, Inc.
$70
Radius Health, Inc.
$65
AbbVie Inc.
$63
Averitas Pharma Inc.
$59
Horizon Therapeutics plc
$58
Allergan, Inc.
$52
ARALEZ PHARMACEUTICALS US INC.
$52
Sumitomo Pharma America, Inc.
$49
Allergan Inc.
$44
Lexicon Pharmaceuticals, Inc.
$39
Bayer Healthcare Pharmaceuticals Inc.
$36
MannKind Corporation
$35
Genentech USA, Inc.
$32
Horizon Pharma plc
$31
Ardelyx, Inc.
$23
RedHill Biopharma Inc.
$21
Acclarent, Inc
$20
Mannkind Corporation
$19
Xeris Pharmaceuticals, Inc.
$19
Phathom Pharmaceuticals, Inc.
$19
Medtronic, Inc.
$17
Vifor Pharma, Inc.
$17
SHIELD THERAPEUTICS INC
$16
Sanofi Pasteur Inc.
$16
Arbor Pharmaceuticals, Inc.
$16
SCILEX PHARMACEUTICALS INC.
$16
Axsome Therapeutics, Inc.
$16
Exact Sciences Corporation
$15
Intuity Medical Inc
$14
Paratek Pharmaceuticals, Inc.
$13
CeQur Corporation
$13
E.R. Squibb & Sons, L.L.C.
$12
Biogen, Inc.
$11
Top 3 companies account for 74.0% of total payments
Associated products mentioned in payments ›
ACCLARENT ENT ULTIRRA/NAVWIRE 3-GUIDE Bundle · ACCRUFER · ADUHELM · AFREZZA · AIRSUPRA · ANORO · AREXVY · Aimovig · Amitiza · Auvelity · BASAGLAR · BELSOMRA · BREO · BREZTRI · BRILINTA · BYDUREON · BYSTOLIC · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CREON · CeQur Simplicity · Cologuard Collection Kit · DUEXIS · Dexcom G6 Transmitter · Dexilant · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FibroScan · FreeStyle Libre blood glucose Flash Monitoring System · GEMTESA · GVOKE PFS · IBSRELA · INVOKAMET · INVOKANA · Inpefa · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LANTUS · LEQVIO · LINZESS · LOKELMA · LYRICA · Leqembi · Livalo · MOUNJARO · MYRBETRIQ · Minimed 770G System · Motegrity · Myrbetriq · NEXLETOL · NEXLIZET · NUZYRA · OFEV · Otezla · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pogo Automatic Blood Glucose Monitoring System · Prolia · QULIPTA · QUTENZA · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYMBICORT · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TZIELD · Talicia · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · Uloric · VESICARE · VOQUEZNA · VRAYLAR · Vascepa · Veltassa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · ZONTIVITY · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for family medicine in TX.

Equivalent to $3,472 per 100 Medicare services performed
Looking for a family medicine in McAllen?
Compare family medicines in the McAllen area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
254
Per 100K population
28.8
County median income
$52,281
Nearest hospital
RIO GRANDE REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Griego is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Griego experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Griego performed 815 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Griego receive payments from pharmaceutical companies?
Yes. Dr. Griego received a total of $215,705 from 59 companies across 1,286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Griego's costs compare to other family medicines in McAllen?
Dr. Griego's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Griego) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →